| Bioactivity | Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research[1]. |
| Target | Immunoglobulin G1; COVID-19 |
| Name | Enibarcimab |
| CAS | 2305638-98-4 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. James E, et al. The Immune System and Chronic Heart Failure: Is the Heart in Control? Journal of the American College of Cardiology. 2019. 53(12):1013-1020. |